 |
Interferon alfa-2a (recombinant) |
|---|---|
| Trade Name | Roferon-A |
| Orphan Indication | For use in combination with fluorouracil for the treatment of esophageal carcinoma |
| USA Market Approval | USA |
| USA Designation Date | 1989-10-27 00:00:00 |
| Sponsor | Hoffmann-La Roche, Inc.;340 Kingsland Street;Nutley, New Jersey, 07110 |
